首页 | 本学科首页   官方微博 | 高级检索  
检索        

抗瘤I号对小鼠脾淋巴细胞增殖及外周血白细胞数的影响
引用本文:雷秀玲,楚延.抗瘤I号对小鼠脾淋巴细胞增殖及外周血白细胞数的影响[J].昆明医学院学报,1996(2).
作者姓名:雷秀玲  楚延
作者单位:昆明医学院药理学教研室,华西医科大学基础药理学教研室
摘    要:抗瘤I号(AT-I)是临床抗肿瘤及辅助肿瘤治疗有效的中药胶囊剂,具有肯定的抑瘤效应及调节小鼠脾细胞IL-2,IL-6产生和NK细胞活性的作用,为了探讨其辅助肿瘤治疗的机理,观察了AT-I对正常、免疫受抑制和荷瘤小鼠脾淋巴细胞增殖和外周血WBC数的影响,结果提示:AT-I低剂量能促进脾细胞增殖,大剂量反呈现抑制效应;同时,AT-I还能纠正环磷酰胺减少外周血WBC数的不良反应.

关 键 词:抗瘤I号(AT-I),免疫抑制,荷瘤小鼠,脾淋巴细胞,白细胞

Effects of AT-I on Murine Lymphocyte Proliferation of Spleen and Numbers of PBWBC
Lei Xiuling,Chu Yan.Effects of AT-I on Murine Lymphocyte Proliferation of Spleen and Numbers of PBWBC[J].Journal of Kunming Medical College,1996(2).
Authors:Lei Xiuling  Chu Yan
Abstract:Antitumor-I(AT-I)is a traditional chinese medicine,which is known to becombined with chemotherapeutic agents on antitumor effects.It is demonstrated that AT-I can inhibit tumor growth and modulate IL-2 ,IL-6 and NK cell activities by splenocytes in vi-vo. In this study,the results suggest that AT-I in lower dose can enhance splenocytes prolif-eration while in higher dose can inhibit it.AT-I can antagonize on adverse reaction of reduc-tion PBWBC when it is combinated with cyclophosphamide(CPA).
Keywords:Antitumor-I(AT-I)  Immunosupression  Splenocyte  Tumor-bearing mice  WBC
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号